P
Perflow Medical
Biotech & Life Sciences · Tel Aviv-Yafo, Israel · Founded 2010
Innovates cutting-edge neurovascular devices that advance the physician's unique skills and expertise by providing real-time control of the device during the procedure to improve overall performance… MoreLess
Perflow Medical, founded in 2010, is a medical device company headquartered in Netanya, Israel, that specializes in developing and commercializing neurovascular intervention technologies. The company was established by co-founders Danny Farin, Dr. Eyal Orion, Gilad Cibulski, and Avi Rappaport, originating from the RAD Biomed Incubator. CEO Danny Farin is a serial entrepreneur with a background in biotechnology engineering and finance, having previously co-founded and led Eon Surgical to a successful acquisition by Teleflex Medical. This experience in the medical device sector has been instrumental in guiding Perflow's strategic growth and commercialization efforts. In January 2022, Perflow Medical was acquired by a Chinese private equity fund for approximately $100 million, a move aimed at accelerating its global expansion.
The company's core business revolves around its proprietary CEREBRAL NET™ technology platform, which features a braided net design that gives physicians real-time control over the device's diameter, length, and radial force during procedures. This platform is the foundation for its product portfolio, which targets neurovascular disorders, primarily ischemic and hemorrhagic strokes. Perflow's clients are hospitals and interventional neuroradiologists who perform complex procedures to treat conditions like brain aneurysms and remove blood clots. The company generates revenue through the sale of its medical devices in Europe, with plans for U.S. market entry pending FDA approval.
Perflow Medical's product line includes the Stream™ Dynamic Neuro-Thrombectomy Net and the Cascade™ Non-Occlusive Remodeling Net. The Stream™ family of products is designed for mechanical thrombectomy to treat acute ischemic stroke by effectively capturing and removing blood clots, even in smaller, more difficult-to-reach vessels. The Cascade™ devices are used for coil embolization of intracranial aneurysms. A key feature of the Cascade™ net is its non-occlusive design, which permits continuous blood flow during the procedure, a significant advantage over some traditional methods. These products have received CE Mark approval and are commercially available in Europe.
Keywords: neurovascular intervention, medical devices, ischemic stroke treatment, hemorrhagic stroke, thrombectomy devices, aneurysm coiling, cerebral net technology, endovascular devices, neuro-interventional devices, brain aneurysm treatment, stentriever, non-occlusive remodeling, stroke care, medical technology, surgical devices, catheter-based technology, vascular intervention, intracranial aneurysms, blood clot removal, medical device manufacturing
Company overview
Perflow Medical company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2010
- Headquarters
- Tel Aviv-Yafo, Israel
- Employees
- 19
- Open positions
- None listed
- Dealroom signal
- 68.9
Valuation & funding
Perflow Medical funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jan 2022 | $100M | $100M | Undisclosed | ↗ |
| EARLY VC✓Equity / VC | Feb 2018 | $12M | $48M | Undisclosed | ↗ |
| SPINOUT✓Other financing | Jan 2010 | $0 | — | Technion Israel Institute of Technology | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 19 |
| 2025 | 21 |
| 2024 | 24 |
| 2023 | 29 |
| 2022 | 27 |
| 2021 | 27 |
| 2020 | 26 |
Growth signals
Perflow Medical website traffic
Latest recorded traffic for Perflow Medical is 1.1K monthly website visits, up 266.7% over the last three months. Perflow Medical's team declined 9.5% over the past year.
Comparisons
Perflow Medical compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Perflow Medical's talent
Source: Dealroom Talent Intelligence.
Investors
2 investors on Perflow Medical's cap table
Sourced from Dealroom's funding and investor records.


Global footprint
Where Perflow Medical has talent and traffic
team presence
In the news
Latest news about Perflow Medical
Recent press, funding announcements, and product moves mentioning Perflow Medical — open to read from the original sources.
Market sentiment
What the market is saying about Perflow Medical
An AI-synthesized read of the highest-engagement posts about Perflow Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Perflow Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







